Found: 7
Select item for more details and to access through your institution.
A mass balance study of [<sup>14</sup>C] SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1116073
- By:
- Publication type:
- Article
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 365, doi. 10.1007/s00262-020-02679-5
- By:
- Publication type:
- Article
Metabolite profiles and mass balance of fuzuloparib, a novel poly (ADP‐ribose) polymerase inhibitor, in subjects with advanced solid cancers.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 7, p. 3307, doi. 10.1111/bcp.15256
- By:
- Publication type:
- Article
Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 1, p. 93, doi. 10.1111/bcp.14363
- By:
- Publication type:
- Article
A retrospective study of the correlation of in vitro chemosensitivity using ATP-TCA with patient clinical outcomes in acute myeloid leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pilot study of a novel nanobody <sup>68</sup> Ga-NODAGA-SNA006 for instant PET imaging of CD8<sup>+</sup> T cells.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4394, doi. 10.1007/s00259-022-05903-9
- By:
- Publication type:
- Article